Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0S1FF
|
||||
| Former ID |
DNC010098
|
||||
| Drug Name |
4-(Isopropylamino)-1-naphthol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H15NO
|
||||
| Canonical SMILES |
CC(C)NC1=CC=C(C2=CC=CC=C21)O
|
||||
| InChI |
1S/C13H15NO/c1-9(2)14-12-7-8-13(15)11-6-4-3-5-10(11)12/h3-9,14-15H,1-2H3
|
||||
| InChIKey |
TWBKFLLEYLZFHH-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Indoleamine 2,3-dioxygenase | Target Info | Inhibitor | [1] | |
| BioCyc Pathway | Superpathway of tryptophan utilization | ||||
| Tryptophan degradation | |||||
| L-kynurenine degradation | |||||
| Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde | |||||
| NAD de novo biosynthesis | |||||
| KEGG Pathway | Tryptophan metabolism | ||||
| Metabolic pathways | |||||
| African trypanosomiasis | |||||
| NetPath Pathway | TSLP Signaling Pathway | ||||
| IL5 Signaling Pathway | |||||
| TGF_beta_Receptor Signaling Pathway | |||||
| PathWhiz Pathway | Tryptophan Metabolism | ||||
| Reactome | Tryptophan catabolism | ||||
| WikiPathways | Tryptophan metabolism | ||||
| Metabolism of amino acids and derivatives | |||||
| References | |||||
| REF 1 | J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.